Biomarkers and cardiovascular disease: determining causality and quantifying contribution to risk assessment

JAMA. 2009 Jul 1;302(1):92-3. doi: 10.1001/jama.2009.949.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Biomarkers / blood*
  • C-Reactive Protein / metabolism
  • Cardiovascular Diseases* / blood
  • Cardiovascular Diseases* / epidemiology
  • Cardiovascular Diseases* / genetics
  • Humans
  • Risk Assessment

Substances

  • Biomarkers
  • C-Reactive Protein